IL6 and hepatocellular carcinoma: For example, human hepatocellular carcinoma-derived CAFs can secrete IL-6, which upregulates the activation of the STAT3 signaling pathway in DCs and creates a regulatory DC (rDC) phenotype that can’t prime and activate T lymphocytes (Cheng et al., 2016).